Global Flu Prevention Market Growth 2026-2032
The global Flu Prevention market size is predicted to grow from US$ 9197 million in 2025 to US$ 13500 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.
Flu prevention encompasses a range of measures aimed at reducing the risk of influenza infection. Key methods include annual vaccination, which is the most effective way to prevent flu, along with practices such as frequent handwashing, avoiding close contact with infected individuals, and maintaining good hygiene. For those at high risk, like young children, elderly adults, and individuals with chronic health conditions, flu prevention is crucial to reduce the chance of severe illness and complications.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
LP Information, Inc. (LPI) ' newest research report, the “Flu Prevention Industry Forecast” looks at past sales and reviews total world Flu Prevention sales in 2025, providing a comprehensive analysis by region and market sector of projected Flu Prevention sales for 2026 through 2032. With Flu Prevention sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flu Prevention industry.
This Insight Report provides a comprehensive analysis of the global Flu Prevention landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flu Prevention portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Flu Prevention market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flu Prevention and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flu Prevention.
This report presents a comprehensive overview, market shares, and growth opportunities of Flu Prevention market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Flu Prevention market?
What factors are driving Flu Prevention market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Flu Prevention market opportunities vary by end market size?
How does Flu Prevention break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Flu prevention encompasses a range of measures aimed at reducing the risk of influenza infection. Key methods include annual vaccination, which is the most effective way to prevent flu, along with practices such as frequent handwashing, avoiding close contact with infected individuals, and maintaining good hygiene. For those at high risk, like young children, elderly adults, and individuals with chronic health conditions, flu prevention is crucial to reduce the chance of severe illness and complications.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
LP Information, Inc. (LPI) ' newest research report, the “Flu Prevention Industry Forecast” looks at past sales and reviews total world Flu Prevention sales in 2025, providing a comprehensive analysis by region and market sector of projected Flu Prevention sales for 2026 through 2032. With Flu Prevention sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flu Prevention industry.
This Insight Report provides a comprehensive analysis of the global Flu Prevention landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flu Prevention portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Flu Prevention market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flu Prevention and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flu Prevention.
This report presents a comprehensive overview, market shares, and growth opportunities of Flu Prevention market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- 6 Months to 3 Years
- > 3 Years
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- BCHT
- Jiangsu GDK
- KM Biologics
What is the 10-year outlook for the global Flu Prevention market?
What factors are driving Flu Prevention market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Flu Prevention market opportunities vary by end market size?
How does Flu Prevention break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Flu Prevention Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Flu Prevention by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Flu Prevention by Country/Region, 2021, 2025 & 2032
2.2 Flu Prevention Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.2.3 Flu Prevention Sales by Type
2.2.3.1 Global Flu Prevention Sales Market Share by Type (2021-2026)
2.2.3.2 Global Flu Prevention Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Flu Prevention Sale Price by Type (2021-2026)
2.3 Flu Prevention Segment by Application
2.3.1 6 Months to 3 Years
2.3.2 > 3 Years
2.3.3 Flu Prevention Sales by Application
2.3.3.1 Global Flu Prevention Sale Market Share by Application (2021-2026)
2.3.3.2 Global Flu Prevention Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Flu Prevention Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Flu Prevention Breakdown Data by Company
3.1.1 Global Flu Prevention Annual Sales by Company (2021-2026)
3.1.2 Global Flu Prevention Sales Market Share by Company (2021-2026)
3.2 Global Flu Prevention Annual Revenue by Company (2021-2026)
3.2.1 Global Flu Prevention Revenue by Company (2021-2026)
3.2.2 Global Flu Prevention Revenue Market Share by Company (2021-2026)
3.3 Global Flu Prevention Sale Price by Company
3.4 Key Manufacturers Flu Prevention Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Flu Prevention Product Location Distribution
3.4.2 Players Flu Prevention Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FLU PREVENTION BY GEOGRAPHIC REGION
4.1 World Historic Flu Prevention Market Size by Geographic Region (2021-2026)
4.1.1 Global Flu Prevention Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Flu Prevention Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Flu Prevention Market Size by Country/Region (2021-2026)
4.2.1 Global Flu Prevention Annual Sales by Country/Region (2021-2026)
4.2.2 Global Flu Prevention Annual Revenue by Country/Region (2021-2026)
4.3 Americas Flu Prevention Sales Growth
4.4 APAC Flu Prevention Sales Growth
4.5 Europe Flu Prevention Sales Growth
4.6 Middle East & Africa Flu Prevention Sales Growth
5 AMERICAS
5.1 Americas Flu Prevention Sales by Country
5.1.1 Americas Flu Prevention Sales by Country (2021-2026)
5.1.2 Americas Flu Prevention Revenue by Country (2021-2026)
5.2 Americas Flu Prevention Sales by Type (2021-2026)
5.3 Americas Flu Prevention Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flu Prevention Sales by Region
6.1.1 APAC Flu Prevention Sales by Region (2021-2026)
6.1.2 APAC Flu Prevention Revenue by Region (2021-2026)
6.2 APAC Flu Prevention Sales by Type (2021-2026)
6.3 APAC Flu Prevention Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Flu Prevention by Country
7.1.1 Europe Flu Prevention Sales by Country (2021-2026)
7.1.2 Europe Flu Prevention Revenue by Country (2021-2026)
7.2 Europe Flu Prevention Sales by Type (2021-2026)
7.3 Europe Flu Prevention Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Flu Prevention by Country
8.1.1 Middle East & Africa Flu Prevention Sales by Country (2021-2026)
8.1.2 Middle East & Africa Flu Prevention Revenue by Country (2021-2026)
8.2 Middle East & Africa Flu Prevention Sales by Type (2021-2026)
8.3 Middle East & Africa Flu Prevention Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flu Prevention
10.3 Manufacturing Process Analysis of Flu Prevention
10.4 Industry Chain Structure of Flu Prevention
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Flu Prevention Distributors
11.3 Flu Prevention Customer
12 WORLD FORECAST REVIEW FOR FLU PREVENTION BY GEOGRAPHIC REGION
12.1 Global Flu Prevention Market Size Forecast by Region
12.1.1 Global Flu Prevention Forecast by Region (2027-2032)
12.1.2 Global Flu Prevention Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Flu Prevention Forecast by Type (2027-2032)
12.7 Global Flu Prevention Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Flu Prevention Product Portfolios and Specifications
13.1.3 Sanofi Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Flu Prevention Product Portfolios and Specifications
13.2.3 CSL Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Flu Prevention Product Portfolios and Specifications
13.3.3 GSK Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Flu Prevention Product Portfolios and Specifications
13.4.3 Viatris Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Flu Prevention Product Portfolios and Specifications
13.5.3 AstraZeneca Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Flu Prevention Product Portfolios and Specifications
13.6.3 Hualan Bio Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Flu Prevention Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Flu Prevention Product Portfolios and Specifications
13.8.3 Sinovac Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 BCHT
13.9.1 BCHT Company Information
13.9.2 BCHT Flu Prevention Product Portfolios and Specifications
13.9.3 BCHT Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BCHT Main Business Overview
13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
13.10.1 Jiangsu GDK Company Information
13.10.2 Jiangsu GDK Flu Prevention Product Portfolios and Specifications
13.10.3 Jiangsu GDK Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jiangsu GDK Main Business Overview
13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Flu Prevention Product Portfolios and Specifications
13.11.3 KM Biologics Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Flu Prevention Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Flu Prevention by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Flu Prevention by Country/Region, 2021, 2025 & 2032
2.2 Flu Prevention Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.2.3 Flu Prevention Sales by Type
2.2.3.1 Global Flu Prevention Sales Market Share by Type (2021-2026)
2.2.3.2 Global Flu Prevention Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Flu Prevention Sale Price by Type (2021-2026)
2.3 Flu Prevention Segment by Application
2.3.1 6 Months to 3 Years
2.3.2 > 3 Years
2.3.3 Flu Prevention Sales by Application
2.3.3.1 Global Flu Prevention Sale Market Share by Application (2021-2026)
2.3.3.2 Global Flu Prevention Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Flu Prevention Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Flu Prevention Breakdown Data by Company
3.1.1 Global Flu Prevention Annual Sales by Company (2021-2026)
3.1.2 Global Flu Prevention Sales Market Share by Company (2021-2026)
3.2 Global Flu Prevention Annual Revenue by Company (2021-2026)
3.2.1 Global Flu Prevention Revenue by Company (2021-2026)
3.2.2 Global Flu Prevention Revenue Market Share by Company (2021-2026)
3.3 Global Flu Prevention Sale Price by Company
3.4 Key Manufacturers Flu Prevention Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Flu Prevention Product Location Distribution
3.4.2 Players Flu Prevention Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FLU PREVENTION BY GEOGRAPHIC REGION
4.1 World Historic Flu Prevention Market Size by Geographic Region (2021-2026)
4.1.1 Global Flu Prevention Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Flu Prevention Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Flu Prevention Market Size by Country/Region (2021-2026)
4.2.1 Global Flu Prevention Annual Sales by Country/Region (2021-2026)
4.2.2 Global Flu Prevention Annual Revenue by Country/Region (2021-2026)
4.3 Americas Flu Prevention Sales Growth
4.4 APAC Flu Prevention Sales Growth
4.5 Europe Flu Prevention Sales Growth
4.6 Middle East & Africa Flu Prevention Sales Growth
5 AMERICAS
5.1 Americas Flu Prevention Sales by Country
5.1.1 Americas Flu Prevention Sales by Country (2021-2026)
5.1.2 Americas Flu Prevention Revenue by Country (2021-2026)
5.2 Americas Flu Prevention Sales by Type (2021-2026)
5.3 Americas Flu Prevention Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flu Prevention Sales by Region
6.1.1 APAC Flu Prevention Sales by Region (2021-2026)
6.1.2 APAC Flu Prevention Revenue by Region (2021-2026)
6.2 APAC Flu Prevention Sales by Type (2021-2026)
6.3 APAC Flu Prevention Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Flu Prevention by Country
7.1.1 Europe Flu Prevention Sales by Country (2021-2026)
7.1.2 Europe Flu Prevention Revenue by Country (2021-2026)
7.2 Europe Flu Prevention Sales by Type (2021-2026)
7.3 Europe Flu Prevention Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Flu Prevention by Country
8.1.1 Middle East & Africa Flu Prevention Sales by Country (2021-2026)
8.1.2 Middle East & Africa Flu Prevention Revenue by Country (2021-2026)
8.2 Middle East & Africa Flu Prevention Sales by Type (2021-2026)
8.3 Middle East & Africa Flu Prevention Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flu Prevention
10.3 Manufacturing Process Analysis of Flu Prevention
10.4 Industry Chain Structure of Flu Prevention
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Flu Prevention Distributors
11.3 Flu Prevention Customer
12 WORLD FORECAST REVIEW FOR FLU PREVENTION BY GEOGRAPHIC REGION
12.1 Global Flu Prevention Market Size Forecast by Region
12.1.1 Global Flu Prevention Forecast by Region (2027-2032)
12.1.2 Global Flu Prevention Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Flu Prevention Forecast by Type (2027-2032)
12.7 Global Flu Prevention Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Flu Prevention Product Portfolios and Specifications
13.1.3 Sanofi Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Flu Prevention Product Portfolios and Specifications
13.2.3 CSL Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Flu Prevention Product Portfolios and Specifications
13.3.3 GSK Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Flu Prevention Product Portfolios and Specifications
13.4.3 Viatris Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Flu Prevention Product Portfolios and Specifications
13.5.3 AstraZeneca Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Flu Prevention Product Portfolios and Specifications
13.6.3 Hualan Bio Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Flu Prevention Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Flu Prevention Product Portfolios and Specifications
13.8.3 Sinovac Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 BCHT
13.9.1 BCHT Company Information
13.9.2 BCHT Flu Prevention Product Portfolios and Specifications
13.9.3 BCHT Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BCHT Main Business Overview
13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
13.10.1 Jiangsu GDK Company Information
13.10.2 Jiangsu GDK Flu Prevention Product Portfolios and Specifications
13.10.3 Jiangsu GDK Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jiangsu GDK Main Business Overview
13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Flu Prevention Product Portfolios and Specifications
13.11.3 KM Biologics Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Flu Prevention Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Flu Prevention Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 6. Global Flu Prevention Sales Market Share by Type (2021-2026)
Table 7. Global Flu Prevention Revenue by Type (2021-2026) & ($ million)
Table 8. Global Flu Prevention Revenue Market Share by Type (2021-2026)
Table 9. Global Flu Prevention Sale Price by Type (2021-2026) & (USD/Doses)
Table 10. Global Flu Prevention Sale by Application (2021-2026) & (M Doses)
Table 11. Global Flu Prevention Sale Market Share by Application (2021-2026)
Table 12. Global Flu Prevention Revenue by Application (2021-2026) & ($ million)
Table 13. Global Flu Prevention Revenue Market Share by Application (2021-2026)
Table 14. Global Flu Prevention Sale Price by Application (2021-2026) & (USD/Doses)
Table 15. Global Flu Prevention Sales by Company (2021-2026) & (M Doses)
Table 16. Global Flu Prevention Sales Market Share by Company (2021-2026)
Table 17. Global Flu Prevention Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Flu Prevention Revenue Market Share by Company (2021-2026)
Table 19. Global Flu Prevention Sale Price by Company (2021-2026) & (USD/Doses)
Table 20. Key Manufacturers Flu Prevention Producing Area Distribution and Sales Area
Table 21. Players Flu Prevention Products Offered
Table 22. Flu Prevention Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Flu Prevention Sales by Geographic Region (2021-2026) & (M Doses)
Table 26. Global Flu Prevention Sales Market Share Geographic Region (2021-2026)
Table 27. Global Flu Prevention Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Flu Prevention Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Flu Prevention Sales by Country/Region (2021-2026) & (M Doses)
Table 30. Global Flu Prevention Sales Market Share by Country/Region (2021-2026)
Table 31. Global Flu Prevention Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Flu Prevention Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Flu Prevention Sales by Country (2021-2026) & (M Doses)
Table 34. Americas Flu Prevention Sales Market Share by Country (2021-2026)
Table 35. Americas Flu Prevention Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 37. Americas Flu Prevention Sales by Application (2021-2026) & (M Doses)
Table 38. APAC Flu Prevention Sales by Region (2021-2026) & (M Doses)
Table 39. APAC Flu Prevention Sales Market Share by Region (2021-2026)
Table 40. APAC Flu Prevention Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 42. APAC Flu Prevention Sales by Application (2021-2026) & (M Doses)
Table 43. Europe Flu Prevention Sales by Country (2021-2026) & (M Doses)
Table 44. Europe Flu Prevention Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 46. Europe Flu Prevention Sales by Application (2021-2026) & (M Doses)
Table 47. Middle East & Africa Flu Prevention Sales by Country (2021-2026) & (M Doses)
Table 48. Middle East & Africa Flu Prevention Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 50. Middle East & Africa Flu Prevention Sales by Application (2021-2026) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Flu Prevention
Table 52. Key Market Challenges & Risks of Flu Prevention
Table 53. Key Industry Trends of Flu Prevention
Table 54. Flu Prevention Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Flu Prevention Distributors List
Table 57. Flu Prevention Customer List
Table 58. Global Flu Prevention Sales Forecast by Region (2027-2032) & (M Doses)
Table 59. Global Flu Prevention Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses)
Table 61. Americas Flu Prevention Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Flu Prevention Sales Forecast by Region (2027-2032) & (M Doses)
Table 63. APAC Flu Prevention Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses)
Table 65. Europe Flu Prevention Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses)
Table 67. Middle East & Africa Flu Prevention Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Flu Prevention Sales Forecast by Type (2027-2032) & (M Doses)
Table 69. Global Flu Prevention Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Flu Prevention Sales Forecast by Application (2027-2032) & (M Doses)
Table 71. Global Flu Prevention Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Flu Prevention Product Portfolios and Specifications
Table 74. Sanofi Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. CSL Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Flu Prevention Product Portfolios and Specifications
Table 79. CSL Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 80. CSL Main Business
Table 81. CSL Latest Developments
Table 82. GSK Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Flu Prevention Product Portfolios and Specifications
Table 84. GSK Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Viatris Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 88. Viatris Flu Prevention Product Portfolios and Specifications
Table 89. Viatris Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 90. Viatris Main Business
Table 91. Viatris Latest Developments
Table 92. AstraZeneca Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Flu Prevention Product Portfolios and Specifications
Table 94. AstraZeneca Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Hualan Bio Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 98. Hualan Bio Flu Prevention Product Portfolios and Specifications
Table 99. Hualan Bio Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 100. Hualan Bio Main Business
Table 101. Hualan Bio Latest Developments
Table 102. Changchun Institute of Biological Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 103. Changchun Institute of Biological Flu Prevention Product Portfolios and Specifications
Table 104. Changchun Institute of Biological Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 105. Changchun Institute of Biological Main Business
Table 106. Changchun Institute of Biological Latest Developments
Table 107. Sinovac Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Flu Prevention Product Portfolios and Specifications
Table 109. Sinovac Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 110. Sinovac Main Business
Table 111. Sinovac Latest Developments
Table 112. BCHT Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 113. BCHT Flu Prevention Product Portfolios and Specifications
Table 114. BCHT Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 115. BCHT Main Business
Table 116. BCHT Latest Developments
Table 117. Jiangsu GDK Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 118. Jiangsu GDK Flu Prevention Product Portfolios and Specifications
Table 119. Jiangsu GDK Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 120. Jiangsu GDK Main Business
Table 121. Jiangsu GDK Latest Developments
Table 122. KM Biologics Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Flu Prevention Product Portfolios and Specifications
Table 124. KM Biologics Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments
Table 1. Flu Prevention Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Flu Prevention Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 6. Global Flu Prevention Sales Market Share by Type (2021-2026)
Table 7. Global Flu Prevention Revenue by Type (2021-2026) & ($ million)
Table 8. Global Flu Prevention Revenue Market Share by Type (2021-2026)
Table 9. Global Flu Prevention Sale Price by Type (2021-2026) & (USD/Doses)
Table 10. Global Flu Prevention Sale by Application (2021-2026) & (M Doses)
Table 11. Global Flu Prevention Sale Market Share by Application (2021-2026)
Table 12. Global Flu Prevention Revenue by Application (2021-2026) & ($ million)
Table 13. Global Flu Prevention Revenue Market Share by Application (2021-2026)
Table 14. Global Flu Prevention Sale Price by Application (2021-2026) & (USD/Doses)
Table 15. Global Flu Prevention Sales by Company (2021-2026) & (M Doses)
Table 16. Global Flu Prevention Sales Market Share by Company (2021-2026)
Table 17. Global Flu Prevention Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Flu Prevention Revenue Market Share by Company (2021-2026)
Table 19. Global Flu Prevention Sale Price by Company (2021-2026) & (USD/Doses)
Table 20. Key Manufacturers Flu Prevention Producing Area Distribution and Sales Area
Table 21. Players Flu Prevention Products Offered
Table 22. Flu Prevention Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Flu Prevention Sales by Geographic Region (2021-2026) & (M Doses)
Table 26. Global Flu Prevention Sales Market Share Geographic Region (2021-2026)
Table 27. Global Flu Prevention Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Flu Prevention Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Flu Prevention Sales by Country/Region (2021-2026) & (M Doses)
Table 30. Global Flu Prevention Sales Market Share by Country/Region (2021-2026)
Table 31. Global Flu Prevention Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Flu Prevention Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Flu Prevention Sales by Country (2021-2026) & (M Doses)
Table 34. Americas Flu Prevention Sales Market Share by Country (2021-2026)
Table 35. Americas Flu Prevention Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 37. Americas Flu Prevention Sales by Application (2021-2026) & (M Doses)
Table 38. APAC Flu Prevention Sales by Region (2021-2026) & (M Doses)
Table 39. APAC Flu Prevention Sales Market Share by Region (2021-2026)
Table 40. APAC Flu Prevention Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 42. APAC Flu Prevention Sales by Application (2021-2026) & (M Doses)
Table 43. Europe Flu Prevention Sales by Country (2021-2026) & (M Doses)
Table 44. Europe Flu Prevention Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 46. Europe Flu Prevention Sales by Application (2021-2026) & (M Doses)
Table 47. Middle East & Africa Flu Prevention Sales by Country (2021-2026) & (M Doses)
Table 48. Middle East & Africa Flu Prevention Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Flu Prevention Sales by Type (2021-2026) & (M Doses)
Table 50. Middle East & Africa Flu Prevention Sales by Application (2021-2026) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Flu Prevention
Table 52. Key Market Challenges & Risks of Flu Prevention
Table 53. Key Industry Trends of Flu Prevention
Table 54. Flu Prevention Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Flu Prevention Distributors List
Table 57. Flu Prevention Customer List
Table 58. Global Flu Prevention Sales Forecast by Region (2027-2032) & (M Doses)
Table 59. Global Flu Prevention Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses)
Table 61. Americas Flu Prevention Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Flu Prevention Sales Forecast by Region (2027-2032) & (M Doses)
Table 63. APAC Flu Prevention Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses)
Table 65. Europe Flu Prevention Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses)
Table 67. Middle East & Africa Flu Prevention Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Flu Prevention Sales Forecast by Type (2027-2032) & (M Doses)
Table 69. Global Flu Prevention Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Flu Prevention Sales Forecast by Application (2027-2032) & (M Doses)
Table 71. Global Flu Prevention Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Flu Prevention Product Portfolios and Specifications
Table 74. Sanofi Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. CSL Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Flu Prevention Product Portfolios and Specifications
Table 79. CSL Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 80. CSL Main Business
Table 81. CSL Latest Developments
Table 82. GSK Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Flu Prevention Product Portfolios and Specifications
Table 84. GSK Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Viatris Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 88. Viatris Flu Prevention Product Portfolios and Specifications
Table 89. Viatris Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 90. Viatris Main Business
Table 91. Viatris Latest Developments
Table 92. AstraZeneca Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Flu Prevention Product Portfolios and Specifications
Table 94. AstraZeneca Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Hualan Bio Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 98. Hualan Bio Flu Prevention Product Portfolios and Specifications
Table 99. Hualan Bio Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 100. Hualan Bio Main Business
Table 101. Hualan Bio Latest Developments
Table 102. Changchun Institute of Biological Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 103. Changchun Institute of Biological Flu Prevention Product Portfolios and Specifications
Table 104. Changchun Institute of Biological Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 105. Changchun Institute of Biological Main Business
Table 106. Changchun Institute of Biological Latest Developments
Table 107. Sinovac Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Flu Prevention Product Portfolios and Specifications
Table 109. Sinovac Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 110. Sinovac Main Business
Table 111. Sinovac Latest Developments
Table 112. BCHT Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 113. BCHT Flu Prevention Product Portfolios and Specifications
Table 114. BCHT Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 115. BCHT Main Business
Table 116. BCHT Latest Developments
Table 117. Jiangsu GDK Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 118. Jiangsu GDK Flu Prevention Product Portfolios and Specifications
Table 119. Jiangsu GDK Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 120. Jiangsu GDK Main Business
Table 121. Jiangsu GDK Latest Developments
Table 122. KM Biologics Basic Information, Flu Prevention Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Flu Prevention Product Portfolios and Specifications
Table 124. KM Biologics Flu Prevention Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Flu Prevention
Figure 2. Flu Prevention Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flu Prevention Sales Growth Rate 2021-2032 (M Doses)
Figure 7. Global Flu Prevention Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Flu Prevention Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Flu Prevention Sales Market Share by Country/Region (2025)
Figure 10. Flu Prevention Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Trivalent Influenza Vaccine
Figure 12. Product Picture of Quadrivalent Influenza Vaccine
Figure 13. Global Flu Prevention Sales Market Share by Type in 2026
Figure 14. Global Flu Prevention Revenue Market Share by Type (2021-2026)
Figure 15. Flu Prevention Consumed in 6 Months to 3 Years
Figure 16. Global Flu Prevention Market: 6 Months to 3 Years (2021-2026) & (M Doses)
Figure 17. Flu Prevention Consumed in > 3 Years
Figure 18. Global Flu Prevention Market: > 3 Years (2021-2026) & (M Doses)
Figure 19. Global Flu Prevention Sale Market Share by Application (2025)
Figure 20. Global Flu Prevention Revenue Market Share by Application in 2026
Figure 21. Flu Prevention Sales by Company in 2026 (M Doses)
Figure 22. Global Flu Prevention Sales Market Share by Company in 2026
Figure 23. Flu Prevention Revenue by Company in 2026 ($ millions)
Figure 24. Global Flu Prevention Revenue Market Share by Company in 2026
Figure 25. Global Flu Prevention Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Flu Prevention Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Flu Prevention Sales 2021-2026 (M Doses)
Figure 28. Americas Flu Prevention Revenue 2021-2026 ($ millions)
Figure 29. APAC Flu Prevention Sales 2021-2026 (M Doses)
Figure 30. APAC Flu Prevention Revenue 2021-2026 ($ millions)
Figure 31. Europe Flu Prevention Sales 2021-2026 (M Doses)
Figure 32. Europe Flu Prevention Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Flu Prevention Sales 2021-2026 (M Doses)
Figure 34. Middle East & Africa Flu Prevention Revenue 2021-2026 ($ millions)
Figure 35. Americas Flu Prevention Sales Market Share by Country in 2026
Figure 36. Americas Flu Prevention Revenue Market Share by Country (2021-2026)
Figure 37. Americas Flu Prevention Sales Market Share by Type (2021-2026)
Figure 38. Americas Flu Prevention Sales Market Share by Application (2021-2026)
Figure 39. United States Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Flu Prevention Sales Market Share by Region in 2026
Figure 44. APAC Flu Prevention Revenue Market Share by Region (2021-2026)
Figure 45. APAC Flu Prevention Sales Market Share by Type (2021-2026)
Figure 46. APAC Flu Prevention Sales Market Share by Application (2021-2026)
Figure 47. China Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 51. India Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Flu Prevention Sales Market Share by Country in 2026
Figure 55. Europe Flu Prevention Revenue Market Share by Country (2021-2026)
Figure 56. Europe Flu Prevention Sales Market Share by Type (2021-2026)
Figure 57. Europe Flu Prevention Sales Market Share by Application (2021-2026)
Figure 58. Germany Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 59. France Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Flu Prevention Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Flu Prevention Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Flu Prevention Sales Market Share by Application (2021-2026)
Figure 66. Egypt Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Flu Prevention in 2026
Figure 72. Manufacturing Process Analysis of Flu Prevention
Figure 73. Industry Chain Structure of Flu Prevention
Figure 74. Channels of Distribution
Figure 75. Global Flu Prevention Sales Market Forecast by Region (2027-2032)
Figure 76. Global Flu Prevention Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Flu Prevention Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Flu Prevention Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Flu Prevention Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Flu Prevention Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Flu Prevention
Figure 2. Flu Prevention Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flu Prevention Sales Growth Rate 2021-2032 (M Doses)
Figure 7. Global Flu Prevention Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Flu Prevention Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Flu Prevention Sales Market Share by Country/Region (2025)
Figure 10. Flu Prevention Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Trivalent Influenza Vaccine
Figure 12. Product Picture of Quadrivalent Influenza Vaccine
Figure 13. Global Flu Prevention Sales Market Share by Type in 2026
Figure 14. Global Flu Prevention Revenue Market Share by Type (2021-2026)
Figure 15. Flu Prevention Consumed in 6 Months to 3 Years
Figure 16. Global Flu Prevention Market: 6 Months to 3 Years (2021-2026) & (M Doses)
Figure 17. Flu Prevention Consumed in > 3 Years
Figure 18. Global Flu Prevention Market: > 3 Years (2021-2026) & (M Doses)
Figure 19. Global Flu Prevention Sale Market Share by Application (2025)
Figure 20. Global Flu Prevention Revenue Market Share by Application in 2026
Figure 21. Flu Prevention Sales by Company in 2026 (M Doses)
Figure 22. Global Flu Prevention Sales Market Share by Company in 2026
Figure 23. Flu Prevention Revenue by Company in 2026 ($ millions)
Figure 24. Global Flu Prevention Revenue Market Share by Company in 2026
Figure 25. Global Flu Prevention Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Flu Prevention Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Flu Prevention Sales 2021-2026 (M Doses)
Figure 28. Americas Flu Prevention Revenue 2021-2026 ($ millions)
Figure 29. APAC Flu Prevention Sales 2021-2026 (M Doses)
Figure 30. APAC Flu Prevention Revenue 2021-2026 ($ millions)
Figure 31. Europe Flu Prevention Sales 2021-2026 (M Doses)
Figure 32. Europe Flu Prevention Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Flu Prevention Sales 2021-2026 (M Doses)
Figure 34. Middle East & Africa Flu Prevention Revenue 2021-2026 ($ millions)
Figure 35. Americas Flu Prevention Sales Market Share by Country in 2026
Figure 36. Americas Flu Prevention Revenue Market Share by Country (2021-2026)
Figure 37. Americas Flu Prevention Sales Market Share by Type (2021-2026)
Figure 38. Americas Flu Prevention Sales Market Share by Application (2021-2026)
Figure 39. United States Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Flu Prevention Sales Market Share by Region in 2026
Figure 44. APAC Flu Prevention Revenue Market Share by Region (2021-2026)
Figure 45. APAC Flu Prevention Sales Market Share by Type (2021-2026)
Figure 46. APAC Flu Prevention Sales Market Share by Application (2021-2026)
Figure 47. China Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 51. India Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Flu Prevention Sales Market Share by Country in 2026
Figure 55. Europe Flu Prevention Revenue Market Share by Country (2021-2026)
Figure 56. Europe Flu Prevention Sales Market Share by Type (2021-2026)
Figure 57. Europe Flu Prevention Sales Market Share by Application (2021-2026)
Figure 58. Germany Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 59. France Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Flu Prevention Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Flu Prevention Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Flu Prevention Sales Market Share by Application (2021-2026)
Figure 66. Egypt Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Flu Prevention Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Flu Prevention in 2026
Figure 72. Manufacturing Process Analysis of Flu Prevention
Figure 73. Industry Chain Structure of Flu Prevention
Figure 74. Channels of Distribution
Figure 75. Global Flu Prevention Sales Market Forecast by Region (2027-2032)
Figure 76. Global Flu Prevention Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Flu Prevention Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Flu Prevention Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Flu Prevention Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Flu Prevention Revenue Market Share Forecast by Application (2027-2032)
